尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Wade Jeffrey l, 首席财务官. Insider active across 1 company, notably Lexicon Pharmaceuticals, INC.. Aggregated, 5 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €34k. History available since 20 June 2023. The latest transaction was disclosed on 14 September 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
WADE JEFFREY L is President and CFO at Lexicon Pharmaceuticals, INC. His 5 filings concern Lexicon Pharmaceuticals, INC., and, across the sampled recent filings from 2022-02-28 to 2024-02-29, the buy amount is EUR 34355, with no reported sells. The most frequent transaction nature is Option exercise.